Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repeated inpatient esketamine courses for pain relief in complex regional pain syndrome
NL-OMON58085Completed
- Sponsor
- Erasmus MC
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of esketamine in complex regional pain syndrome (CRPS), sponsored by Erasmus MC. Primary endpoints: Change in pain relief between first and subsequent courses and Duration of analgesia. Started Jan 2026; status: completed.
02
Drugs
esketamine
03
Conditions
complex regional pain syndrome (CRPS)
Beyond the preview
Go deeper on NL-OMON58085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON58085.